Peter J. Pitts
Latest Articles
Sorry, but the 'drugs from Canada' don't work
First, how much would all the added risk to the safety and effectiveness of medicines from importation save US consumers? Hardly anything.
Rehire NYC workers who refused the vax: Doing right will help us all
Rehire all the city workers who stood up for their principles (whether you agree or not). They all deserve back pay. And they deserve our respect. All of them. Mr....
Biden's fantasyland Medicare plan would mean even more American life years lost
President Joe Biden announced a plan Tuesday to keep Medicare solvent by relying on even more aggressive price negotiations with the pharmaceutical industry.
Uh-oh, he's back: Fauci is once again spouting bad COVID advice
We should target those citizens most at risk with solid information on infection-mitigation strategies (including wearing masks more regularly). But returning to a one-size-fits-all recommendation for indoor masking is bad...
Here's why it's taking so long to fix the baby formula shortage
Who’s to blame for the baby-formula shortage and why is it taking so long to fix the problem?
Focus on vaxxing the unvaxxed — not boosting the booster
Another booster for vaccinated Americans is an interesting conversation, but it is far from the most important asset in our health-care arsenal.
Please, New Yorkers, just let it slide! We’re masking ourselves into fits
Taking off your mask isn’t a victory for “the other side.” It is a public-health victory for all of us. We’ve worked hard for it. We’ve earned it. And our...
The hedge-fund ploy that's aborting miracle medicines
Hedge-fund investors are coming to raid your medicine cabinet. Cutting-edge treatments for diseases affecting millions of Americans are threatened by Wall Street’s latest moneymaking scheme. The ploy: Hedge funds bet...
Why people don't trust drug makers
When former hedge-fund manager and current Turing Pharmaceuticals chief executive Martin Shkreli hiked the price of his generic anti-parasitic drug pyrimethamine from $13.50 to $750 per pill, he invited understandable...
From HIV to cancer to Crohn's, ObamaCare fails the sick
It turns out ObamaCare didn’t solve the problem of “pre-existing conditions” after all. It made premiums more affordable for people with chronic health conditions that are expensive to treat —...
Why 'pricey' drugs save money -- and lives
Expensive new drugs often get fingered as the culprit to rising US health-care costs. The truth is closer to the reverse. First off, it’s hard to see how pharmaceuticals can...